Voronoi, Inc
310210 · KOSDAQ
Public Market Listing
310210KOSDAQ
Live quotes, historical charts, and market capitalization for Voronoi, Inc are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(2 total)
2Total Assets
0Approved
0Phase 3 / Filed
2Phase 1–2 / Early
1Diseases
| Target & Modality | |||
|---|---|---|---|
| Phase 1/2 | EGFR/HER2Small molecule | Non-Small Cell Lung Cancer | |
| Phase 1/2 | EGFRSmall molecule | Non-Small Cell Lung Cancer |
Upcoming events
(2 total)
Estimated primary-completion dates from ClinicalTrials.gov and expected earnings reports. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Add these trial readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.
2027 (1)
June 2027 (1)
Est. primary completion 2027-06 · NCT05315700 · CT.gov ↗
What to watch
Financial reports
No financial reports recorded.